Company profile: Savsu
1.1 - Company Overview
Company description
- Provider of integrated, innovative hardware and software solutions designed to protect live cell therapies during transport and storage, serving cell and gene therapy companies, specialty couriers, biotech/biopharma, research institutions, governments, and NGOs.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Savsu
PreOmics
HQ: Germany
Website
- Description: Provider of innovative pre-analytics and sample preparation technologies for MS-based proteomics, supporting researchers in protein analysis. Offerings include iST kits for protein/peptide prep, TMT/iTRAQ-compatible chemical labeling (iST-NHS), minimized modifications in biofluids (iST-BCT), high-throughput positive-pressure prep (iST-PSI), peptide clean-up (iST Phoenix), and GFP IP enrichment (iST-Trap).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PreOmics company profile →
Torax Biosciences
HQ: United Kingdom
Website
- Description: Provider of innovative quality controls and IVD reagents for clinical laboratories, creating, developing, and producing these products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Torax Biosciences company profile →
Definigen
HQ: United Kingdom
Website
- Description: Provider of in-vitro liver and metabolic disease models using iPSC technology to generate pre-clinical human data, offering Opti-HEPs for drug efficacy and predictive toxicology screening, phenotypic screening with bioassays, and custom disease model development via CRISPR. Includes models for Alpha-1 Antitrypsin Deficiency, Wilson's Disease (ATP7B), and Glycogen Storage Disease Type 1 Alpha.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Definigen company profile →
Avalyn Pharma
HQ: United States
Website
- Description: Provider of inhaled therapies for idiopathic pulmonary fibrosis and other respiratory diseases, advancing direct-lung delivery candidates including AP01 (Phase 2b-ready inhaled pirfenidone), AP02 (reformulated inhaled nintedanib; Phase 1a completed), AP02-DP (dry powder nintedanib with equivalent pulmonary bioavailability), AP03 (fixed-dose inhaled pirfenidone+nintedanib), and AP04 (inhaled imatinib for PAH).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avalyn Pharma company profile →
Magtivio
HQ: The Netherlands
Website
- Description: Provider of magnetic micro- and nano particles and complete kits for DNA extraction, circulating cfDNA analysis, NGS library preparation, and dye-terminator removal in Sanger sequencing, as well as magnetic separators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magtivio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Savsu
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Savsu
2.2 - Growth funds investing in similar companies to Savsu
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Savsu
4.2 - Public trading comparable groups for Savsu
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →